Prognostic Factors of Guillain-Barre Syndrome After Intravenous Immunoglobulin or Plasma Exchange?
Neurol 53:598-604, Visser,L.H.,et al, 1999
Neurologic Complications Associated with Hepatitis C Virus Infection
Neurol 53:861-864, Tembl,J.I.,et al, 1999
SIADH as the First Symptom of Guillain-Barre Syndrome
Neurol 53:1365, Hofmann,O.,et al, 1999
Ramsay Hunt Syndrome Associated with Brain Stem Enhancement
AJNR 20:278-280, Sartoretti-Schefer,S.,et al, 1999
Fatal Guillain-Barre Syndrome
Neurol 52:635-638, Lawn,N.D.&Wijdicks,E.F.M., 1999
The Spectrum of Antecedent Infections in Guillain-Barre Syndrome
Neurol 51:1110-1115, Jacobs,B.C.,et al, 1998
The Guillain-Barre Syndrome and the 1992-1993 and 1993-1994 Influenza Vaccines
NEJM 339:1797-1802,1845, Lasky,T.,et al, 1998
Acute Inflammatory Demyelinating Polyradiculopathy in Children:Clinical and Electrodiagnostic Studies
Ann Neurol 44:350-356, Delanoe,C.,et al, 1998
Minimal Number of Plasma Exchanges Needed to Reduce Immunoglobulin in Guillain-Barre Syndrome
Neurol 51:875-877, Yuki,N.,et al, 1998
Alcohol-Related Acute Axonal Polyneuropathy,A Differential Diagnosis of Guillain-Barre Syndrome
Arch Neurol 55:1329-1334, Wohrle,J.C.,et al, 1998
Respiratory Management in Acute Neurologic Illness
Neurol 50:11-20, Wijdicks,E.F.M.&Borel,C.O., 1998
Secondary Hyperkalaemic Paralysis
JNNP 64:249-252, Evers,S.,et al, 1998
Guillain-Barre Syndrome
Lancet 352:635-641, Hahn,A.F., 1998
Guillain-Barre Syndrome:MR Imaging Findings of the Spine in Eight Patients
Radiology 208:137-141, Byun,W.M.,et al, 1998
Fulminant Demyelinating Neuropathy Mimicking Cerebral Death
Muscle & Nerve 20:1595-1597997., Bakshi,N.,et al, 1997
An Acute Neurologic Syndrome Temporally Associated with Postexposure Trtm of Rabies
Pediatrics 100:720-721, Mortiere,M.D.&Falcone,A.L., 1997
Guillain-Barre Syndrome Following Allogeneic Bone Marrow Transplantation
Neurol 49:1711-1714, Wen,P.Y.,et al, 1997
Clinicopath Conf
Botulism, Case 22-1997, NEJM 337:184-190997., , 1997
CIDP:Clinical Features & Responses to Trtm in 67 Consecutive Pts with/without a Monoclonal Gammopathy
Neurol 48:321-328, Gorson,K.G.,et al, 1997
Intravenous Immune Globulin Therapy for Neurologic Diseases
Ann Int Med 126:721-730, Dalakas,M.C., 1997
Appropriate Number of Plasma Exchanges in Guillain-Barre Syndrome
French Coop Grp on Plasma Exchange in GBS, Ann Neurol 41:298-306, 287997., , 1997
Pain in Guillain-Barre Syndrome
Neurol 48:328-331, Moulin,D.E.,et al, 1997
Measles Vaccination and Guillain-Barre Syndrome
349:14-16, daSilveira,C.M.,et al, 1997
Acute Paresis of Extraocular Muscles Associated with IgG Anti-GQ Antibody
Ann Neurol 39:668-672, Yuki,N., 1996
Twelfth-Nerve Palsy:Analysis of 100 Cases
Arch Neurol 53:561-566, Keane,J.R., 1996
Cranial Nerve Enhancement on Three-Dimentional MRI in Miller Fisher Syndrome
Neurol 47:1601-1602, Nagaoka,U.,et al, 1996
Acute Demyelinating Polyneuropathy with Arsenic Ingestion
Muscle & Nerve 19:1611-1613996., Greenberg,S.A., 1996
Taste Loss as an Initial Symptom of Guillain-Barre Syndrome
Neurol 47:1604-1605, Combarros,O.,et al, 1996
Idiopathic Acute Transverse Myelitis:MR Imaging Findings
Radiology 201:661-669, Tartaglino,L.M.,et al, 1996
Reversible Encephalopathy with Cerebral Vasospasm in a Guillain-Barre Syndrome Patient Treated with Intravenous Immunoglobulin
Neurol 46:250-251, Voltz,R.,et al, 1996
Liver Function Disturbances in Guillain-Barre Syndrome:A Prospective Longitudinal Study in 100 Patients
Neurol 46:96-100, Oomes,P.G.,et al, 1996
Pilot Trial of Immunoglobulin Versus Plasma Exchange in Patients with Guillain-Barre Syndrome
Neurol 46:100-103, Bril,V.,et al, 1996
Campylobacter Jejuni Infection and Anti-GM1 Antibodies in Guillain-Barre Syndrome
Ann Neurol 40:181-187, Jacobs,B.C.,et al, 1996
Intravenous Immunoglobulin Treatment of Neurological Disease
JNNP 60:359-361, Otten,A.,et al, 1996
Cost-Effectiveness Analysis:What Is It and How Will It Influence Neurology
Ann Neurol 39:818-823, Holloway,R.G., 1996
Cytomegalovirus Infection and Guillain-Barre Syndrome:The Clinical, Electrophysiologic, and Prognostic Features
Neurol 47:668-673, Visser,L.H.,et al, 1996
Prospective Evaluation of MRI Lumbosacral Nerve Root Enhancement in Acute Guillain-Barre Syndrome
Neurol 47:813-817, Gorson,K.C.,et al, 1996
Intravenous IgG in Guillain-Barre Syndrome
BMJ 313:376-377, Hughes,R.A.C., 1996
Lyme Radiculoneuritis Treated with Intravenous Immunoglobin
Neurol 46:1174-1175, Crisp,D.&Ashby,P., 1996
Idiopathic Dysautonomia Treated with Intravenous Gammaglobulin
Lancet 347:28-29, Heafield,M.T.E.,et al, 1996
Childhood Leukemia:Central Nervous System Abnormalities During and After Treatment
AJNR 17:295-310, Chen,C-Y.,et al, 1996
Age and Guillain-Barre Syndrome Severity
Muscle & Nerve 19:375-377996., Sheth,R.D.,et al, 1996
Autonomic Ganglionitis with Severe Hypertension, Migraine, and Episodic but Fatal Hypotension
Neurol 47:817-821, Lee,H.C.,et al, 1996
Diphtheritic Neuropathy
Muscle & Nerve 18:1460-1463995., Greange,A.,et al, 1995
Campylobacter Jejuni Infection and Guillain-Barre Syndrome
NEJM 333:1374-1379, 14151995., Rees,J.H.,et al, 1995
Cranial Nerve Enhancement in the Guillain-Barre Syndrome
AJNR 16:923-925, Fulbright,R.K.,et al, 1995
Lyme Neuroborreliosis
Ann Neurol 37:691-702, Garcia-Monco,J.C.&Benach,J.L., 1995
Fisher Syndrome after Campylobacter Jejuni Enteritis:Human Leukocyte Antigen and the Bacterial Serotype
J Pediatr 126:55-57, Yuki,N.,et al, 1995
Neurologic Aspects of Inflammatory Bowel Disease
Neurol 45:416-421, Lossos,A.,et al, 1995
The Clinical Correlates of High-Titer IgG Anti-GM1 Antibodies
Ann Neurol 35:234-237, Kornberg,A.J.,et al, 1994